2026 AI and Robotics Funding Rounds and Infrastructure Investments
The cycle includes seed to series rounds for AI platforms, large AI infrastructure financing, multiple robotics startups raising capital, and a biotech seed round for mitochondrial therapeutics.
Compiled automatically from the sources listed below and checked against Hyperuranios' own capital and research data. Every figure here traces to a linked source.
Artificial Intelligence
Antares Labs announced a public launch backed by a $7.25 million seed round that included Fifth Wall, Base10 Partners, Bloomberg Beta and Sandwith Ventures, aiming to build company‑specific AI systems for large real‑estate owners, developers, investors and asset managers; the financing will be used to expand its platform and forward‑deployed teams that embed within customer organisations to tailor AI around data, workflows and institutional knowledge [1].
Microsoft disclosed plans to invest roughly $80 billion in fiscal year 2025 to expand its data‑center network, with more than half allocated to the United States, to strengthen AI and cloud infrastructure needed for training and deploying sophisticated models; the company’s capital expenditure rose 5.3% to $20 billion in the first quarter, underscoring the scale of the commitment [6].
Robotics
The weekly robotics roundup reported that Atoms raised $1.7 billion in a venture round from Andreessen Horowitz and Uber to automate the physical world; Gritt secured $26 million Series A led by Obvious Ventures after a $6.4 million pre‑seed to convert existing construction equipment into autonomous machines; Humanoid raised $152 million Series A led by Prime Movers Lab at a $1.35 billion valuation to mass‑manufacture wheeled humanoid robots for industrial use; Perceptual Robotics obtained £4 million (about $5.3 million) from One Planet Capital, Loggerhead Ventures and Investing for Purpose for offshore wind‑turbine inspection drones; and Ropedia raised $30 million across two pre‑Series A rounds to scale its head‑mounted data‑collection hardware and AI platform for physical‑world training data [2].
Generalist AI, founded in 2024 by former DeepMind and Boston Dynamics researchers, is in talks for a new funding round that could value the company at $3 billion after a $400 million raise at a $2 billion valuation led by Radical Ventures with participation from 8VC, Union Square Ventures, Nvidia and Bezos Expeditions; the startup builds AI brains for robots, with its GEN‑1 model enabling tasks such as laundry folding, Lego sorting and whisk‑based mixing [3].
Automated Industrial Robotics (AIR), founded in 2023 by Brian Klos and Darragh de Stonndún, pursues an engineering‑led acquisition model to integrate companies sharing collaborative culture, delivering shared expertise across pharmaceutical production, precision assembly and complex systems integration, and offering long‑term engineering support rather than project‑based delivery; no financing details were disclosed [4].
UNIT AI raised $12 million co‑led by Prologis Ventures, Dynamo Ventures and Ground Up Ventures, with participation from eGateway Capital, Recursive Ventures, Think + Ventures, ZEP Fund and Crosscourt, to accelerate commercial deployments of its modular AI‑powered platform for end‑to‑end ecommerce fulfillment and returns across North America, expanding deployment capacity, product innovation and commercial growth for retailers and third‑party logistics providers [5].
One Robot, a Y Combinator‑backed startup, builds realistic simulation environments that allow robotics teams to train and evaluate policies without relying on physical robot time, focusing on task‑specific data for hard manipulation tasks such as textiles and box folding, thereby accelerating iteration and reducing dependence on real‑world data collection [7].
American Industrial Partners completed its acquisition of Honeywell Technologies Warehouse and Workflow Solutions, merging Intelligrated, Trew and Transnorm into a single organisation focused on warehouse automation; the combined entity, generating over $1 billion in 2025 revenue and employing more than 3,700 staff, offers an integrated portfolio of equipment, software and services under CEO Alfred Rebello [8].
Genetic Engineering
Adjuvia Therapeutics closed an $8 million Series Seed financing led by JLO Ventures with participation from Portfolia Ventures, to fund an IND submission for its lead mitochondrial therapeutic ATI‑105 and launch a Phase 1 trial in healthy volunteers in fall 2026, followed by a Phase 1/2 study in Friedreich’s ataxia in early 2027; the biotech develops a BBB‑penetrant lipid nanoparticle formulation of a novel astaxanthin molecule targeting oxidative stress, chronic inflammation and organ degeneration [9].